236 related articles for article (PubMed ID: 26569409)
1. Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma.
Fang JZ; Li C; Liu XY; Hu TT; Fan ZS; Han ZG
PLoS One; 2015; 10(11):e0143042. PubMed ID: 26569409
[TBL] [Abstract][Full Text] [Related]
2. Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.
Hu C; Li W; Tian F; Jiang K; Liu X; Cen J; He Q; Qiu Z; Kienast Y; Wang Z; Zhang H; Ji Y; Hu J; Hui L
J Hepatol; 2018 Mar; 68(3):465-475. PubMed ID: 29113912
[TBL] [Abstract][Full Text] [Related]
3. ARID1A represses hepatocellular carcinoma cell proliferation and migration through lncRNA MVIH.
Cheng S; Wang L; Deng CH; Du SC; Han ZG
Biochem Biophys Res Commun; 2017 Sep; 491(1):178-182. PubMed ID: 28716731
[TBL] [Abstract][Full Text] [Related]
4. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.
Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H
J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
[TBL] [Abstract][Full Text] [Related]
7. Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.
Sun X; Wang SC; Wei Y; Luo X; Jia Y; Li L; Gopal P; Zhu M; Nassour I; Chuang JC; Maples T; Celen C; Nguyen LH; Wu L; Fu S; Li W; Hui L; Tian F; Ji Y; Zhang S; Sorouri M; Hwang TH; Letzig L; James L; Wang Z; Yopp AC; Singal AG; Zhu H
Cancer Cell; 2017 Nov; 32(5):574-589.e6. PubMed ID: 29136504
[TBL] [Abstract][Full Text] [Related]
8. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
Zhang W; Zhangyuan G; Wang F; Jin K; Shen H; Zhang L; Yuan X; Wang J; Zhang H; Yu W; Huang R; Xu X; Yin Y; Zhong G; Lin A; Sun B
Immunity; 2021 Jun; 54(6):1168-1185.e8. PubMed ID: 34038747
[TBL] [Abstract][Full Text] [Related]
9. Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.
Ni Q; Ding K; Wang KQ; He J; Yin C; Shi J; Zhang X; Xie WF; Shi YQ
FEBS Lett; 2017 Jul; 591(13):1947-1957. PubMed ID: 28547778
[TBL] [Abstract][Full Text] [Related]
10. Induction of Steatohepatitis and Liver Tumorigenesis by Enforced Snail Expression in Hepatocytes.
Miura S; Suzuki A
Am J Pathol; 2020 Jun; 190(6):1271-1283. PubMed ID: 32188584
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.
Horie Y; Suzuki A; Kataoka E; Sasaki T; Hamada K; Sasaki J; Mizuno K; Hasegawa G; Kishimoto H; Iizuka M; Naito M; Enomoto K; Watanabe S; Mak TW; Nakano T
J Clin Invest; 2004 Jun; 113(12):1774-83. PubMed ID: 15199412
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the SWI/SNF Component Arid1a Promotes Mammalian Regeneration.
Sun X; Chuang JC; Kanchwala M; Wu L; Celen C; Li L; Liang H; Zhang S; Maples T; Nguyen LH; Wang SC; Signer RA; Sorouri M; Nassour I; Liu X; Xu J; Wu M; Zhao Y; Kuo YC; Wang Z; Xing C; Zhu H
Cell Stem Cell; 2016 Apr; 18(4):456-66. PubMed ID: 27044474
[TBL] [Abstract][Full Text] [Related]
13. ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis.
Shang XY; Shi Y; He DD; Wang L; Luo Q; Deng CH; Qu YL; Wang N; Han ZG
Cell Death Dis; 2021 Oct; 12(11):990. PubMed ID: 34689165
[TBL] [Abstract][Full Text] [Related]
14. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.
Umemura A; Park EJ; Taniguchi K; Lee JH; Shalapour S; Valasek MA; Aghajan M; Nakagawa H; Seki E; Hall MN; Karin M
Cell Metab; 2014 Jul; 20(1):133-44. PubMed ID: 24910242
[TBL] [Abstract][Full Text] [Related]
15. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
[TBL] [Abstract][Full Text] [Related]
17. [Tumor suppressor gene PTEN and non-alcoholic steatohepatitis (NASH)].
Sato W; Horie Y; Watanabe S; Suzuki A
Nihon Rinsho; 2005 Aug; 63(8):1475-83. PubMed ID: 16101243
[TBL] [Abstract][Full Text] [Related]
18. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
Zhang W; Hou J; Wang X; Jiang R; Yin Y; Ji J; Deng L; Huang X; Wang K; Sun B
Oncotarget; 2015 Apr; 6(11):9420-33. PubMed ID: 25826083
[TBL] [Abstract][Full Text] [Related]
19. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.
Bard-Chapeau EA; Li S; Ding J; Zhang SS; Zhu HH; Princen F; Fang DD; Han T; Bailly-Maitre B; Poli V; Varki NM; Wang H; Feng GS
Cancer Cell; 2011 May; 19(5):629-39. PubMed ID: 21575863
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
